Global Parkinson's Disease Therapeutics Market Research Report 2024(Status and Outlook)

Global Parkinson's Disease Therapeutics Market Research Report 2024(Status and Outlook)



Report Overview:

Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of the disease.

The Global Parkinson's Disease Therapeutics Market Size was estimated at USD 2646.12 million in 2023 and is projected to reach USD 3753.57 million by 2029, exhibiting a CAGR of 6.00% during the forecast period.

This report provides a deep insight into the global Parkinson's Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Parkinson's Disease Therapeutics Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Parkinson's Disease Therapeutics market in any manner.

Global Parkinson's Disease Therapeutics Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Merck

Akorn

GSK

Novartis

Boehringer Ingelheim

Teva Pharmaceutical

Abbvie

Kyowa Hakko Kirin Pharma

Astellas Pharma

Roche

H.Lundbeck

Bausch Health

Apokyn

Orion

Stada Arzneimittel

US WorldMeds

Desitin Arzneimittel

Endo Pharmaceuticals

Market Segmentation (by Type)

Sinemet-CR

Trastal

Madopar

COMT Inhibitor

Other

Market Segmentation (by Application)

Under 40 Years Old

40-65 Years Old

Above 65 Years Old

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Parkinson's Disease Therapeutics Market

Overview of the regional outlook of the Parkinson's Disease Therapeutics Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors

You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents

The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly

Provision of market value (USD Billion) data for each segment and sub-segment

Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market

Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region

Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled

Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players

The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions

Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis

Provides insight into the market through Value Chain

Market dynamics scenario, along with growth opportunities of the market in the years to come

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Parkinson's Disease Therapeutics Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Parkinson's Disease Therapeutics
1.2 Key Market Segments
1.2.1 Parkinson's Disease Therapeutics Segment by Type
1.2.2 Parkinson's Disease Therapeutics Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Parkinson's Disease Therapeutics Market Overview
2.1 Global Market Overview
2.1.1 Global Parkinson's Disease Therapeutics Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Parkinson's Disease Therapeutics Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Parkinson's Disease Therapeutics Market Competitive Landscape
3.1 Global Parkinson's Disease Therapeutics Sales by Manufacturers (2019-2024)
3.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Manufacturers (2019-2024)
3.3 Parkinson's Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Parkinson's Disease Therapeutics Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Parkinson's Disease Therapeutics Sales Sites, Area Served, Product Type
3.6 Parkinson's Disease Therapeutics Market Competitive Situation and Trends
3.6.1 Parkinson's Disease Therapeutics Market Concentration Rate
3.6.2 Global 5 and 10 Largest Parkinson's Disease Therapeutics Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Parkinson's Disease Therapeutics Industry Chain Analysis
4.1 Parkinson's Disease Therapeutics Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Parkinson's Disease Therapeutics Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Parkinson's Disease Therapeutics Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Parkinson's Disease Therapeutics Sales Market Share by Type (2019-2024)
6.3 Global Parkinson's Disease Therapeutics Market Size Market Share by Type (2019-2024)
6.4 Global Parkinson's Disease Therapeutics Price by Type (2019-2024)
7 Parkinson's Disease Therapeutics Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Parkinson's Disease Therapeutics Market Sales by Application (2019-2024)
7.3 Global Parkinson's Disease Therapeutics Market Size (M USD) by Application (2019-2024)
7.4 Global Parkinson's Disease Therapeutics Sales Growth Rate by Application (2019-2024)
8 Parkinson's Disease Therapeutics Market Segmentation by Region
8.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.1 Global Parkinson's Disease Therapeutics Sales by Region
8.1.2 Global Parkinson's Disease Therapeutics Sales Market Share by Region
8.2 North America
8.2.1 North America Parkinson's Disease Therapeutics Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Parkinson's Disease Therapeutics Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Parkinson's Disease Therapeutics Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Parkinson's Disease Therapeutics Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Parkinson's Disease Therapeutics Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Merck
9.1.1 Merck Parkinson's Disease Therapeutics Basic Information
9.1.2 Merck Parkinson's Disease Therapeutics Product Overview
9.1.3 Merck Parkinson's Disease Therapeutics Product Market Performance
9.1.4 Merck Business Overview
9.1.5 Merck Parkinson's Disease Therapeutics SWOT Analysis
9.1.6 Merck Recent Developments
9.2 Akorn
9.2.1 Akorn Parkinson's Disease Therapeutics Basic Information
9.2.2 Akorn Parkinson's Disease Therapeutics Product Overview
9.2.3 Akorn Parkinson's Disease Therapeutics Product Market Performance
9.2.4 Akorn Business Overview
9.2.5 Akorn Parkinson's Disease Therapeutics SWOT Analysis
9.2.6 Akorn Recent Developments
9.3 GSK
9.3.1 GSK Parkinson's Disease Therapeutics Basic Information
9.3.2 GSK Parkinson's Disease Therapeutics Product Overview
9.3.3 GSK Parkinson's Disease Therapeutics Product Market Performance
9.3.4 GSK Parkinson's Disease Therapeutics SWOT Analysis
9.3.5 GSK Business Overview
9.3.6 GSK Recent Developments
9.4 Novartis
9.4.1 Novartis Parkinson's Disease Therapeutics Basic Information
9.4.2 Novartis Parkinson's Disease Therapeutics Product Overview
9.4.3 Novartis Parkinson's Disease Therapeutics Product Market Performance
9.4.4 Novartis Business Overview
9.4.5 Novartis Recent Developments
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Parkinson's Disease Therapeutics Basic Information
9.5.2 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Overview
9.5.3 Boehringer Ingelheim Parkinson's Disease Therapeutics Product Market Performance
9.5.4 Boehringer Ingelheim Business Overview
9.5.5 Boehringer Ingelheim Recent Developments
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Parkinson's Disease Therapeutics Basic Information
9.6.2 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Overview
9.6.3 Teva Pharmaceutical Parkinson's Disease Therapeutics Product Market Performance
9.6.4 Teva Pharmaceutical Business Overview
9.6.5 Teva Pharmaceutical Recent Developments
9.7 Abbvie
9.7.1 Abbvie Parkinson's Disease Therapeutics Basic Information
9.7.2 Abbvie Parkinson's Disease Therapeutics Product Overview
9.7.3 Abbvie Parkinson's Disease Therapeutics Product Market Performance
9.7.4 Abbvie Business Overview
9.7.5 Abbvie Recent Developments
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Basic Information
9.8.2 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Overview
9.8.3 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Product Market Performance
9.8.4 Kyowa Hakko Kirin Pharma Business Overview
9.8.5 Kyowa Hakko Kirin Pharma Recent Developments
9.9 Astellas Pharma
9.9.1 Astellas Pharma Parkinson's Disease Therapeutics Basic Information
9.9.2 Astellas Pharma Parkinson's Disease Therapeutics Product Overview
9.9.3 Astellas Pharma Parkinson's Disease Therapeutics Product Market Performance
9.9.4 Astellas Pharma Business Overview
9.9.5 Astellas Pharma Recent Developments
9.10 Roche
9.10.1 Roche Parkinson's Disease Therapeutics Basic Information
9.10.2 Roche Parkinson's Disease Therapeutics Product Overview
9.10.3 Roche Parkinson's Disease Therapeutics Product Market Performance
9.10.4 Roche Business Overview
9.10.5 Roche Recent Developments
9.11 H.Lundbeck
9.11.1 H.Lundbeck Parkinson's Disease Therapeutics Basic Information
9.11.2 H.Lundbeck Parkinson's Disease Therapeutics Product Overview
9.11.3 H.Lundbeck Parkinson's Disease Therapeutics Product Market Performance
9.11.4 H.Lundbeck Business Overview
9.11.5 H.Lundbeck Recent Developments
9.12 Bausch Health
9.12.1 Bausch Health Parkinson's Disease Therapeutics Basic Information
9.12.2 Bausch Health Parkinson's Disease Therapeutics Product Overview
9.12.3 Bausch Health Parkinson's Disease Therapeutics Product Market Performance
9.12.4 Bausch Health Business Overview
9.12.5 Bausch Health Recent Developments
9.13 Apokyn
9.13.1 Apokyn Parkinson's Disease Therapeutics Basic Information
9.13.2 Apokyn Parkinson's Disease Therapeutics Product Overview
9.13.3 Apokyn Parkinson's Disease Therapeutics Product Market Performance
9.13.4 Apokyn Business Overview
9.13.5 Apokyn Recent Developments
9.14 Orion
9.14.1 Orion Parkinson's Disease Therapeutics Basic Information
9.14.2 Orion Parkinson's Disease Therapeutics Product Overview
9.14.3 Orion Parkinson's Disease Therapeutics Product Market Performance
9.14.4 Orion Business Overview
9.14.5 Orion Recent Developments
9.15 Stada Arzneimittel
9.15.1 Stada Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.15.2 Stada Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.15.3 Stada Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.15.4 Stada Arzneimittel Business Overview
9.15.5 Stada Arzneimittel Recent Developments
9.16 US WorldMeds
9.16.1 US WorldMeds Parkinson's Disease Therapeutics Basic Information
9.16.2 US WorldMeds Parkinson's Disease Therapeutics Product Overview
9.16.3 US WorldMeds Parkinson's Disease Therapeutics Product Market Performance
9.16.4 US WorldMeds Business Overview
9.16.5 US WorldMeds Recent Developments
9.17 Desitin Arzneimittel
9.17.1 Desitin Arzneimittel Parkinson's Disease Therapeutics Basic Information
9.17.2 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Overview
9.17.3 Desitin Arzneimittel Parkinson's Disease Therapeutics Product Market Performance
9.17.4 Desitin Arzneimittel Business Overview
9.17.5 Desitin Arzneimittel Recent Developments
9.18 Endo Pharmaceuticals
9.18.1 Endo Pharmaceuticals Parkinson's Disease Therapeutics Basic Information
9.18.2 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Overview
9.18.3 Endo Pharmaceuticals Parkinson's Disease Therapeutics Product Market Performance
9.18.4 Endo Pharmaceuticals Business Overview
9.18.5 Endo Pharmaceuticals Recent Developments
10 Parkinson's Disease Therapeutics Market Forecast by Region
10.1 Global Parkinson's Disease Therapeutics Market Size Forecast
10.2 Global Parkinson's Disease Therapeutics Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.3 Asia Pacific Parkinson's Disease Therapeutics Market Size Forecast by Region
10.2.4 South America Parkinson's Disease Therapeutics Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Parkinson's Disease Therapeutics by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Parkinson's Disease Therapeutics Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Parkinson's Disease Therapeutics by Type (2025-2030)
11.1.2 Global Parkinson's Disease Therapeutics Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Parkinson's Disease Therapeutics by Type (2025-2030)
11.2 Global Parkinson's Disease Therapeutics Market Forecast by Application (2025-2030)
11.2.1 Global Parkinson's Disease Therapeutics Sales (K Units) Forecast by Application
11.2.2 Global Parkinson's Disease Therapeutics Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings